QVT Financial’s Sarepta Therapeutics SRPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-3,117
| Closed | -$379K | – | 42 |
|
|
2024
Q4 | $379K | Hold |
3,117
| – | – | 0.03% | 32 |
|
|
2024
Q3 | $389K | Hold |
3,117
| – | – | 0.03% | 32 |
|
|
2024
Q2 | $492K | Hold |
3,117
| – | – | 0.05% | 28 |
|
|
2024
Q1 | $405K | Hold |
3,117
| – | – | 0.03% | 31 |
|
|
2023
Q4 | $301K | Hold |
3,117
| – | – | 0.02% | 32 |
|
|
2023
Q3 | $378K | Hold |
3,117
| – | – | 0.02% | 37 |
|
|
2023
Q2 | $357K | Hold |
3,117
| – | – | 0.02% | 42 |
|
|
2023
Q1 | $430K | Hold |
3,117
| – | – | 0.02% | 49 |
|
|
2022
Q4 | $404K | Hold |
3,117
| – | – | 0.02% | 47 |
|
|
2022
Q3 | $345K | Hold |
3,117
| – | – | 0.02% | 53 |
|
|
2022
Q2 | $234K | Hold |
3,117
| – | – | 0.01% | 62 |
|
|
2022
Q1 | $244K | Hold |
3,117
| – | – | 0.01% | 68 |
|
|
2021
Q4 | $281K | Hold |
3,117
| – | – | 0.01% | 60 |
|
|
2021
Q3 | $288K | Hold |
3,117
| – | – | 0.02% | 61 |
|
|
2021
Q2 | $242K | Hold |
3,117
| – | – | 0.02% | 54 |
|
|
2021
Q1 | $232K | Hold |
3,117
| – | – | 0.02% | 51 |
|
|
2020
Q4 | $531K | Hold |
3,117
| – | – | 0.03% | 50 |
|
|
2020
Q3 | $438K | Hold |
3,117
| – | – | 0.05% | 48 |
|
|
2020
Q2 | $500K | Hold |
3,117
| – | – | 0.09% | 47 |
|
|
2020
Q1 | $305K | Hold |
3,117
| – | – | 0.07% | 46 |
|
|
2019
Q4 | $402K | Hold |
3,117
| – | – | 0.08% | 47 |
|
|
2019
Q3 | $235K | Hold |
3,117
| – | – | 0.05% | 53 |
|
|
2019
Q2 | $474K | Hold |
3,117
| – | – | 0.1% | 48 |
|
|
2019
Q1 | $372K | Sell |
3,117
-345
| -10% | -$44.4K | 0.09% | 46 |
|
|
2018
Q4 | $378K | Hold |
3,462
| – | – | 0.12% | 46 |
|
|
2018
Q3 | $559K | Hold |
3,462
| – | – | 0.14% | 46 |
|
|
2018
Q2 | $458K | Sell |
3,462
-3,269
| -49% | -$308K | 0.13% | 46 |
|
|
2018
Q1 | $499K | Sell |
6,731
-10,500
| -61% | -$700K | 0.05% | 49 |
|
|
2017
Q4 | $959K | Sell |
17,231
-39,718
| -70% | -$2.1M | 0.05% | 52 |
|
|
2017
Q3 | $2.58M | Sell |
56,949
-53,863
| -49% | -$2.15M | 0.1% | 55 |
|
|
2017
Q2 | $3.73M | Sell |
110,812
-110,879
| -50% | -$3.61M | 0.1% | 54 |
|
|
2017
Q1 | $6.56M | Buy |
221,691
+8,915
| +4% | +$276K | 0.2% | 52 |
|
|
2016
Q4 | $5.84M | Sell |
212,776
-283,658
| -57% | -$11.4M | 0.18% | 62 |
|
|
2016
Q3 | $30.5M | Buy |
496,434
+85,357
| +21% | +$2.58M | 1.15% | 15 |
|
|
2016
Q2 | $7.84M | Sell |
411,077
-38,449
| -9% | -$712K | 0.54% | 48 |
|
|
2016
Q1 | $8.78M | Buy |
449,526
+325,676
| +263% | +$5.69M | 0.54% | 49 |
|
|
2015
Q4 | $4.78M | Buy |
+123,850
| New | +$4.02M | 0.27% | 64 |
|
Other funds holding SRPT
ACA
FCM
QVT Financial's SRPT Position: Q1 2025 in Review
QVT Financial sold out of Sarepta Therapeutics (SRPT) in Q1 2025, closing a stake of 3,117 shares — an estimated $379K sold.
QVT Financial first reported a position in SRPT in Q4 2015 and held it in 37 quarters. The position peaked at $30.5M in Q3 2016. 430 funds tracked by Wall St. Rank hold SRPT as of Q1 2025.
- QVT Financial reported no remaining Sarepta Therapeutics position as of Q1 2025 after selling out during the quarter.
- QVT Financial sold 3,117 Sarepta Therapeutics shares in Q1 2025, an estimated $379K.
- QVT Financial first reported a position in Sarepta Therapeutics in Q4 2015 and held it in 37 quarters.
- QVT Financial's Sarepta Therapeutics position peaked at $30.5M in Q3 2016.
- 430 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2025.
Based on QVT Financial's 13F filing for Q1 2025, filed 15 May 2025.